Search

everythinglearnresearchcommunity

for

Search:↓

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.

Oral mini-pulse methylprednisolone is an effective and safe treatment for alopecia areata.

Pulse corticosteroid therapy helps many with severe alopecia areata regrow hair, but has side effects.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Twice-weekly 5 mg dexamethasone can effectively treat extensive alopecia areata in many patients.

Combining oral methylprednisolone with microneedle radiofrequency improves hair growth in alopecia areata but may cause pain and side effects.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Weekly Azathioprine Pulse therapy is more effective than Betamethasone Oral Mini-Pulse for hair regrowth in moderate to severe Alopecia Areata.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Laser hair removal can cause a severe itchy rash in some allergic individuals, treatable with steroids.

The rash worsened due to a fungal infection masked by corticosteroids.

Current treatments for alopecia show no significant long-term benefits.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Hair and nails can help diagnose diseases, with nail issues often linked to skin conditions and hair loss having various causes and treatments.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

Different hair and nail conditions can indicate health issues and have specific treatments; accurate diagnosis is crucial before treatment.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Combining OMP with cyclosporine can effectively treat severe alopecia areata in children.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.